| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.0007 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.18 | 0.001 |